|
US3853893A
(en)
*
|
1973-04-02 |
1974-12-10 |
Squibb & Sons Inc |
Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
|
|
HU177086B
(en)
*
|
1975-06-09 |
1981-07-28 |
Eszakmagyar Vegyimuevek |
Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
|
|
JPS58150576A
(ja)
*
|
1982-03-03 |
1983-09-07 |
Sumitomo Chem Co Ltd |
新規な1,2,4−オキサジアゾ−ル誘導体
|
|
DE3247118A1
(de)
*
|
1982-12-20 |
1984-06-20 |
Cassella Ag, 6000 Frankfurt |
Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
EP1582519A3
(en)
*
|
1999-08-19 |
2005-12-21 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
KR100875222B1
(ko)
*
|
1999-08-19 |
2008-12-19 |
아스트라제네카 아베 |
헤테로폴리사이클릭 화합물 및 간접 글루타메이트 수용체길항제로서의 그들의 용도
|
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
ES2292830T3
(es)
*
|
2001-02-21 |
2008-03-16 |
Astrazeneca Ab |
Compuestos heteropoliciclicos y su uso como antagonistas del receptor metabotropico de glutamato.
|
|
CA2495179A1
(en)
|
2002-08-09 |
2004-02-19 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
|
CA2520255C
(en)
*
|
2003-04-09 |
2014-07-08 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
|
WO2004103279A2
(en)
*
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
|
US20060189661A1
(en)
*
|
2003-11-03 |
2006-08-24 |
Wagenen Bradford V |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2005060961A2
(en)
*
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
|
CN1898235A
(zh)
*
|
2003-12-24 |
2007-01-17 |
普罗西迪恩有限公司 |
作为gpcr受体激动剂的杂环衍生物
|
|
WO2005077368A2
(en)
*
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
RU2007139255A
(ru)
*
|
2005-04-26 |
2009-06-10 |
Ньюросерч А/С (DK) |
Новые оксадиазольные производные и их медицинское применение
|
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
|
KR101370280B1
(ko)
|
2005-07-26 |
2014-03-06 |
바이알 - 포르텔라 앤드 씨에이 에스에이 |
Comt 억제제로서의 니트로카테콜 유도체
|
|
EP1845097A1
(en)
*
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazole derivatives as COMT inhibitors
|
|
ES2400533T3
(es)
*
|
2006-09-07 |
2013-04-10 |
Actelion Pharmaceuticals Ltd. |
Derivados de piridin 4-ilo como agentes inmunomoduladores
|
|
NZ576059A
(en)
*
|
2006-09-08 |
2012-03-30 |
Actelion Pharmaceuticals Ltd |
Pyridin-3-yl derivatives as immunomodulating agents
|
|
US8524746B2
(en)
|
2007-01-31 |
2013-09-03 |
Bial-Portela & Ca., S.A. |
Dosage regimen for COMT inhibitors
|
|
PT2125797E
(pt)
*
|
2007-03-16 |
2014-03-11 |
Actelion Pharmaceuticals Ltd |
Derivados aminopiridina como agonistas do receptor s1p1/edg1
|
|
MY153975A
(en)
*
|
2007-08-17 |
2015-04-30 |
Actelion Pharmaceuticals Ltd |
Pyridine derivatives as s1p1/edg1 receptor modulators
|
|
AU2009217865A1
(en)
*
|
2008-02-28 |
2009-09-03 |
Bial - Portela & Ca., S.A. |
Pharmaceutical composition for poorly soluble drugs
|
|
ES2389042T3
(es)
*
|
2008-03-06 |
2012-10-22 |
Actelion Pharmaceuticals Ltd. |
Compuestos de piridina
|
|
US8575200B2
(en)
*
|
2008-03-07 |
2013-11-05 |
Actelion Pharmaceuticals Ltd |
Pyridin-2-yl derivatives as immunomodulating agents
|
|
TW200942531A
(en)
|
2008-03-17 |
2009-10-16 |
Bial Portela & Companhia S A |
Crystal forms of a nitrocatechol
|
|
NZ589617A
(en)
*
|
2008-05-14 |
2012-06-29 |
Scripps Research Inst |
3-(Inden-4-yl)-5-(phenyl)-1,2,4-oxadiazole and 3-(tetralin-5-yl)-5-(phenyl)-1,2,4-oxadiazole derivatives
|
|
EP3587413A1
(en)
|
2009-02-10 |
2020-01-01 |
Monsanto Technology LLC |
Compositions and methods for controlling nematodes comprising oxadiazoles
|
|
BRPI1016132B8
(pt)
*
|
2009-04-01 |
2021-05-25 |
Bial Portela & Ca Sa |
composição, formulação farmacêutica, processo de obtenção de uma formulação farmacêutica estável
|
|
CN102448444B
(zh)
|
2009-04-01 |
2016-05-25 |
巴尔-波特拉及康邦亚股份有限公司 |
包括硝基儿茶酚衍生物的药物制剂及其制备方法
|
|
CA2767585C
(en)
|
2009-07-16 |
2017-09-26 |
Actelion Pharmaceuticals Ltd |
Pyridin-4-yl derivatives
|
|
HRP20150919T1
(hr)
|
2011-01-19 |
2015-09-25 |
Actelion Pharmaceuticals Ltd. |
Derivati 2-metoksi-piridin-4-ila
|
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
|
HRP20192133T8
(hr)
|
2011-12-13 |
2021-02-19 |
BIAL - PORTELA & Cª S.A. |
Kemijski spoj koristan kao posrednik za pripremu inhibitora katekol-o-metiltransferaze
|
|
WO2014127195A1
(en)
|
2013-02-15 |
2014-08-21 |
Monsanto Technology Llc |
3,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles for controlling nematode pests
|
|
WO2016083863A1
(en)
|
2014-11-28 |
2016-06-02 |
Bial - Portela & Ca, S.A. |
Medicaments for slowing parkinson's disease
|
|
RS59788B1
(sr)
|
2015-05-20 |
2020-02-28 |
Idorsia Pharmaceuticals Ltd |
Kristalni oblik jedinjenja (s)-3-{4-[5-(2-ciklopentil-6-metoksi-piridin-4-il)-[1,2,4]oksadiazol-3-il]-2-etil-6-metil-fenoksi}-propan-1,2-diola
|